Verhaar, Barbara J. H.
Bouwmeester, Thomas A.
Galenkamp, Henrike
van den Born, Bert-Jan H.
Nieuwdorp, Max
Funding for this research was provided by:
Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers
ZonMw (09150162410064)
ZonMw (09150182010020)
European Research Council (101141346)
Hartstichting (01-001-2024-0601)
Article History
Received: 8 September 2025
Accepted: 23 February 2026
First Online: 7 March 2026
Competing interests
: M.N. is on the Scientific Advisory Board of Caelus Pharmaceuticals and Advanced Microbiome Interventions, the Netherlands. However, none of these bear direct relevance to the current manuscript. The other authors declare no competing financial or non-financial interests.